Natural Product: NPC476382

Natural Product IDNPC476382
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(2R,3R,4R,5R,6R)-5-Hydroxy-2-(Hydroxymethyl)-6-[2-(4-Hydroxyphenyl)Ethoxy]-4-[[(2S,3R,4R,5R,6S)-3,4,5-Trihydroxy-6-Methyloxan-2-Yl]Methoxy]Oxan-3-Yl] (E)-3-(4-Hydroxy-3-Methoxyphenyl)Prop-2-Enoate
IUPAC Name [(2R,3R,4R,5R,6R)-5-hydroxy-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]-4-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]methoxy]oxan-3-yl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate
Synonyms Syringalide A 3'-O-Rha
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL590396
PubChem CID 46228755
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000476] Cinnamic acids and derivatives
        • [CHEMONTID:0001391] Hydroxycinnamic acids and derivatives
          • [CHEMONTID:0000059] Coumaric acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VCVDCGNCACPEQN-MXIJRSCASA-N
Standard InCHI InChI=1S/C31H40O14/c1-16-25(36)27(38)26(37)23(43-16)15-42-30-28(39)31(41-12-11-17-3-7-19(33)8-4-17)44-22(14-32)29(30)45-24(35)10-6-18-5-9-20(34)21(13-18)40-2/h3-10,13,16,22-23,25-34,36-39H,11-12,14-15H2,1-2H3/b10-6+/t16-,22+,23-,25-,26-,27+,28+,29+,30+,31+/m0/s1
SMILES CC1C(C(C(C(O1)COC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)OC)CO)OCCC4=CC=C(C=C4)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   636.24 Volume:   612.478
?
Van der Waals volume.
Dense:   1.039 LogP:   0.532
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.015
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.677
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   13.0 Rigid Bonds:   26.0
TPSA:   214.06
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   7.0 Rings:   4.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.117 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.675 Fsp3:   0.516
MCE-18:   95.915
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.389 Fluc inhibitor:   0.618
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.151
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.888
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.157 Promiscuous compounds:   0.362

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.259 MDCK Permeability:   -5.29
Pgp-inhibitor:   0.0 Pgp-substrate:   0.984
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.985
20% Bioavailability (F20%):   0.892 30% Bioavailability (F30%):   0.98
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.886
Plasma Protein Binding (PPB):   67.451% Volume Distribution (VD):   -0.413
Fu: 34.045%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.018
OATP1B3 inhibitor:   0.984 BCRP inhibitor:   0.322
BSEP inhibitor:   0.067

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.643 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.978 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.087 CYP2D6-substrate:   0.026
CYP3A4-inhibitor:   0.001 CYP3A4-substrate:   0.016
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.931
HLM stability:   0.929
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.021 Half-life (T1/2):  2.824

ADMET: Toxicity

hERG Blockers:  0.122 hERG Blockers (10um):  0.623
Human Hepatotoxicity (H-HT):  0.443 Drug-induced Liver Injury (DILI):  0.146
AMES Toxicity:  0.833 Rat Oral Acute Toxicity:  0.183
Maximum Recommended Daily Dose:  0.213 Skin Sensitization:  0.901
Carcinogencity:  0.05 Eye Corrosion:  0.0
Eye Irritation:  0.006 Respiratory Toxicity:  0.019
Drug-induced Neurotoxicity:  0.341 Ototoxicity:  0.971
Hematotoxicity:  0.021 Drug-induced Nephrotoxicity:  0.163
Genotoxicity:  0.082 RPMI-8226 Immunitoxicity:  0.118
A549 Cytotoxicity:  0.269 Hek293 Cytotoxicity:  0.918
BCF:   0.578
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.093
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.956
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.965
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota fresh stems n.a. n.a. PMID[20159656]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO6964 Cistanche tubulosa Species Orobanchaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 9.7 % PMID[25871261]
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 21.4 % DOI[10.6019/CHEMBL1201861]
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 35.7 % PMID[25127165]
NPT993 Cell line Hepatocyte Mus musculus Inhibition = 55.7 % PMID[16933872]
NPT993 Cell line Hepatocyte Mus musculus IC50 = 71200.0 nM PMID[25856683]
NPT1460 Cell line L929 Mus musculus Inhibition = 4.5 % PMID[22671987]
NPT1460 Cell line L929 Mus musculus Inhibition = 4.6 % PubChem BioAssay data set
NPT1460 Cell line L929 Mus musculus Inhibition = 13.3 % PMID[15787444]
NPT1460 Cell line L929 Mus musculus Inhibition = 22.2 % DrugMatrix in vitro pharmacology data

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC476382 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7426 Intermediate Similarity NPC476386
0.7204 Intermediate Similarity NPC34587
0.6979 Remote Similarity NPC100998
0.6979 Remote Similarity NPC34927
0.6733 Remote Similarity NPC476381
0.6569 Remote Similarity NPC476380
0.6522 Remote Similarity NPC46137
0.6346 Remote Similarity NPC471062
0.6226 Remote Similarity NPC306890
0.6224 Remote Similarity NPC476385
0.6214 Remote Similarity NPC476384
0.6168 Remote Similarity NPC94871
0.6168 Remote Similarity NPC473427
0.6122 Remote Similarity NPC263829
0.61 Remote Similarity NPC252292
0.6038 Remote Similarity NPC470933
0.6019 Remote Similarity NPC259347
0.5882 Remote Similarity NPC112
0.5859 Remote Similarity NPC476377
0.5859 Remote Similarity NPC476383
0.5833 Remote Similarity NPC470934
0.5714 Remote Similarity NPC472350
0.5714 Remote Similarity NPC197316
0.5714 Remote Similarity NPC89105
0.5648 Remote Similarity NPC476378
0.5429 Remote Similarity NPC600370
0.5385 Remote Similarity NPC269141
0.5385 Remote Similarity NPC470927
0.5385 Remote Similarity NPC257970
0.5321 Remote Similarity NPC476375
0.53 Remote Similarity NPC483706
0.5248 Remote Similarity NPC483705
0.5116 Remote Similarity NPC213552
0.5048 Remote Similarity NPC106677
0.5048 Remote Similarity NPC47471
0.5046 Remote Similarity NPC96795
0.5046 Remote Similarity NPC264632

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476382 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5714 Remote Similarity NPD7266 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data